Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease
Author(s) -
Isabel Weigand,
Lisanne Knobloch,
Jörg Flitsch,
Wolfgang Saeger,
Camelia M. Monoranu,
Kerstin Höfner,
Sabine Herterich,
Roman Rotermund,
Cristina L. Ronchi,
Michael Buchfelder,
Markus Glatzel,
Christian Hagel,
Martin Faßnacht,
Timo Deutschbein,
Silviu Sbiera
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-02564
Subject(s) - biology , cancer research , microbiology and biotechnology , creb , corticotropic cell , carcinogenesis , transcription factor , endocrinology , gene , genetics , pituitary gland , hormone
Cushing disease (CD) is a rare disorder with severe sequels and incompletely understood pathogenesis. The underlying corticotroph adenomas harbor frequently somatic mutations in the ubiquitin-specific peptidase 8 (USP8) gene. These mutations render USP8 hyperactive and prevent client proteins from degradation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom